- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
Bellicum Pharmaceuticals is a biotechnology business based in the US. Bellicum Pharmaceuticals shares (BLCM) are listed on the PINK and all prices are listed in US Dollars. Bellicum Pharmaceuticals employs 13 staff and has a trailing 12-month revenue of around $1.5 million.
What's in this guide?
Our top picks for where to buy Bellicum Pharmaceuticals stock
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Complimentary access to a financial planner
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
How to buy Bellicum Pharmaceuticals stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – BLCM. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Bellicum Pharmaceuticals stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Bellicum Pharmaceuticals stock price (PINK: BLCM)
Use our graph to track the performance of BLCM stocks over time.Bellicum Pharmaceuticals shares at a glance
52-week range | $0.07 - $0.29 |
---|---|
50-day moving average | $0.11 |
200-day moving average | $0.26 |
Wall St. target price | $5.00 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-0.67 |
Bellicum Pharmaceuticals financials
Revenue TTM | $1.5 million |
---|---|
Gross profit TTM | $-17,378,000 |
Return on assets TTM | -78.1% |
Return on equity TTM | -148.5% |
Profit margin | 0% |
Book value | $-2.78 |
Market Capitalization | $778,326 |
TTM: trailing 12 months
Bellicum Pharmaceuticals share dividends
We're not expecting Bellicum Pharmaceuticals to pay a dividend over the next 12 months.
Have Bellicum Pharmaceuticals's shares ever split?
Bellicum Pharmaceuticals's shares were split on a 1:10 basis on 5 February 2020 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Bellicum Pharmaceuticals shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Bellicum Pharmaceuticals shares which in turn could have impacted Bellicum Pharmaceuticals's share price.
Bellicum Pharmaceuticals share price volatility
Over the last 12 months, Bellicum Pharmaceuticals's shares have ranged in value from as little as $0.065 up to $0.289. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Bellicum Pharmaceuticals's is 1.382. This would suggest that Bellicum Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Bellicum Pharmaceuticals overview
Bellicum Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem cell antigen. Its clinical product candidates also include BPX-603, an autologous dual-switch GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing human epidermal growth factor receptor 2 antigen. It has collaboration and license agreements with Adaptimmune Therapeutics plc; Agensys, Inc. ; BioVec Pharma, Inc. ; ARIAD Pharmaceuticals, Inc.
Frequently asked questions
nullWhat percentage of Bellicum Pharmaceuticals is owned by insiders or institutions?
Currently 0.987% of Bellicum Pharmaceuticals shares are held by insiders and 32.908% by institutions. How many people work for Bellicum Pharmaceuticals?
Latest data suggests 13 work at Bellicum Pharmaceuticals. When does the fiscal year end for Bellicum Pharmaceuticals?
Bellicum Pharmaceuticals's fiscal year ends in December. Where is Bellicum Pharmaceuticals based?
Bellicum Pharmaceuticals's address is: 3730 Kirby Drive, Houston, TX, United States, 77098 What is Bellicum Pharmaceuticals's ISIN number?
Bellicum Pharmaceuticals's international securities identification number is: US0794814048 What is Bellicum Pharmaceuticals's CUSIP number?
Bellicum Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 079481404
More guides on Finder
-
Robinhood Now Let’s You Trade on the Outcome of the Presidential Election; Joining Kalshi and others.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
Trading for Beginners: 9 Best Trading Platforms to Get Started
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
-
SoFi Invest vs. Robinhood
Compare pros, cons, research tools and reviews for these two trading platforms.
-
10 Best Stock Apps of 2024 to Elevate Your Mobile Trading
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
-
10 Best Brokerage Accounts for Trading and Investing in 2024
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to Invest $10K
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
-
How to Invest $20K: 8 Ways to Maximize Earnings
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
-
Robinhood Review 2024: IRA Match and No Commissions
A deep dive into the highlights and limitations of Robinhood.
Ask a question